| Preview | Issue Date | Title / Name | Author(s) |
| Jul-2021 | Immunotherapy-related gastritis: Two case reports and literature review | Woodford, R.; Briscoe, K.; Tustin, R.; Jain, A.; Briscoe, Karen; Tustin, Richard; Jain, Ankit | |
| Aug-2021 | MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG) | Siu, H. W. D.; Tebbutt, N.; Chantrill, L.; Karapetis, C.; Steer, C.; Wilson, K.; Espinoza, D.; Bailey, L.; Yip, S.; Cuff, J.; Pavlakis, N.; Thavaneswaran, S.; Briscoe, K.; Srivastav, R.; Shannon, J.; Segelov, E.; Tie, J.; Caird, S.; Francesconi, A.; Price, T.; Wuttke, M.; Ladwa, R.; Sjoquist, K.; Burge, M.; Briscoe, Karen | |
| Aug-2024 | Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial. | Grimison, P.; Mersiades, A.; Kirby, A.; Tognela, A.; Olver, I.; Morton, R. L.; Haber, P.; Walsh, A.; Lee, Y.; Abdi, E.; Della-Fiorentina, S.; Aghmesheh, M.; Fox, P.; Briscoe, K.; Sanmugarajah, J.; Marx, G.; Kichenadasse, G.; Wheeler, H.; Chan, M.; Shannon, J.; Gedye, C.; Begbie, S.; et al.; Begbie, Stephen; Briscoe, Karen | |
| Nov-2015 | A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial | Davidson, A; Veillard, A-S; Tognela, A.; Chan, M. M. K.; Hughes, B. G. M.; Boyer, M.; Briscoe, K.; Begbie, S.; Abdi, E.; Crombie, C.; Long, J.; Boyce, A.; Lewis, C. R.; Varma, S.; Broad, A.; Muljadi, M.; Chinchen, S.; Espinoza, D.; Coskinas, X.; Pavlakis, N.; Millward, M.; Stockler, M. R.; Australasian Lung cancer Trials Group ALTG; Briscoe, Karen; Begbie, Stephen | |
